Other products — Total revenues
Amgen Other products — Total revenues decreased by 26.3% to $1.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.2%, from $1.65B to $1.53B. Over 3 years (FY 2022 to FY 2025), Other products — Total revenues shows an upward trend with a 12.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful commercialization or sustained demand for secondary assets, while a decrease may indicate product maturity, loss of exclusivity, or a strategic shift away from these therapeutic areas.
Detailed definition
This metric represents the aggregate gross revenue generated from the company's portfolio of secondary or non-core thera...
Peer comparison
Peers in the biotechnology and pharmaceutical sectors typically report similar 'Other' or 'Miscellaneous' product categories, which are often used to aggregate smaller revenue contributors that do not meet the threshold for individual segment reporting.
amgn_segment_other_products_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.47B | $1.73B | $1.48B | $1.59B | $1.63B | $359.00M | $1.70B | $1.73B | $1.64B | $0.00 | $1.37B | $1.33B | $1.36B | $1.57B | $1.65B | $1.69B | $1.85B | $2.07B | $1.53B |
| QoQ Change | — | +17.4% | -14.5% | +7.6% | +2.5% | -77.9% | +372.1% | +2.1% | -5.4% | -100.0% | — | -3.4% | +2.8% | +15.0% | +5.0% | +2.6% | +9.6% | +11.9% | -26.3% |
| YoY Change | — | — | — | +8.0% | -5.7% | — | +14.8% | +9.0% | +0.6% | -100.0% | -19.0% | -23.4% | -16.7% | — | +20.0% | +27.5% | +36.0% | +32.2% | -7.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's other products — total revenues?
- Amgen (AMGN) reported other products — total revenues of $1.53B in Q1 2026.
- How has Amgen's other products — total revenues changed year-over-year?
- Amgen's other products — total revenues decreased by 7.2% year-over-year, from $1.65B to $1.53B.
- What is the long-term trend for Amgen's other products — total revenues?
- Over 3 years (2022 to 2025), Amgen's other products — total revenues has grown at a 12.9% compound annual growth rate (CAGR), from $5.05B to $7.26B.
- What does other products — total revenues mean?
- The total revenue generated from the company's secondary or non-core therapeutic product lines.